5 results for “Carbapenem Resistance”

Set a search alert

Research ArticleOpen accessPhrase in the titleFrequency of Carbapenem Resistance among Gram Negative Pathogens in a Tertiary Care Hospital in Southern PakistanWaseela Ashraf, Altaf AhmedCarbapenems are considered the treatment of choice for treating the multi-drug resistance Gram negative bacteria. But resistance to these antibiotics has increased worldwide thus limiting therapeutic options for clinicians. To investigate the frequency and Minimum Inhibitory Concentrations (MICs) of carbapenem resistance in Gram negative organisms at a tertiary care hospital in Southern Pakistan. Seven Hundred and ninety-three carbapenem resistant isolates … …American Journal of Infectious Diseases, Vol. 11, Issue 4 · 29 Oct 2015 · 7,573 accessesView PDF Cite

Research ArticleOpen accessPhrase in the titleImpact of Antimicrobial Stewardship Programme on Carbapenem Resistance in Gram Negative Isolates in an Indian Tertiary Care HospitalNamita Jaggi, Pushpa Sissodia, Lalit SharmaProblem statement: Increasing Antimicrobial resistance in the World is constantly becoming a Global threat and there is an urgent need to prevent its spread. Various studies of last decade have shown reduced trends of antimicrobial resistance in the pathogens as an outcome of the Antimicrobial Stewardship Programs. In view of this, the present four years’ study was carried out to … …American Journal of Infectious Diseases, Vol. 8, Issue 2 · 2 Oct 2012 · 7,626 accessesView PDF Cite

Review ArticleOpen accessEvery word in the titleCarbapenem-Resistant Enterobacteriaceae in Korean Elderly Nursing Hospitals in 2023: Prevalence, Mortality, and Resistance PatternsLee Hye Seong, Jang Sung Hun, Kim Jae KyungInfections caused by Carbapenem-Resistant Enterobacteriaceae (CRE) represent a critical threat in healthcare settings owing to limited therapeutic options and high associated mortality. However, the epidemiological patterns and dynamics of CRE transmission in geriatric care hospitals remain poorly characterized. We elucidated the monthly incidence, bacterial species distribution, resistance genotypes, and patient demographics of CRE infections among inpatients at a senior care … …American Journal of Biochemistry and Biotechnology, Vol. 21, Issue 4 · 30 Jan 2026 · 2,101 accessesView PDF Cite

Research ArticleOpen accessIn the abstractDistribution and Risk Factors of Carbapenem-Resistant Enterobacterales in General Hospitals in South KoreaMijin Kang, Bokyeung Jung, Jaekyung KimThe emergence of Carbapenem-Resistant Enterobacterales (CRE) presents a significant global health challenge due to its high resistance to broad-spectrum β-lactam antibiotics. CRE infections are increasingly common in hospital settings and are associated with high mortality rates. In South Korea, the increase in CRE infections necessitates a detailed investigation into their distribution and risk factors to inform effective management and prevention … …American Journal of Biochemistry and Biotechnology, Vol. 21, Issue 1 · 27 Mar 2025 · 5,759 accessesView PDF Cite

Research ArticleOpen accessIn the abstractPharmacodynamic Comparison of the Carbapenems Against E. coli and Klebsiella spp. Containing Extended spectrum β-lactamasesKathryn J. Eagye, Joseph L. Kuti, David P. NicolauCarbapenems are the treatment of choice for extended-spectrum β-lactamases (ESBLs). Ertapenem is a new member of the carbapenem class, and is often grouped with imipenem and meropenem as a recommended treatment for ESBLs. However, new in vitro data question ertapenem’s inclusion as a first line treatment for these bacteria, suggesting that ertapenem has a lower likelihood of obtaining appropriate pharmacodynamic … …American Journal of Infectious Diseases, Vol. 1, Issue 3 · 30 Sep 2005 · 6,886 accessesView PDF Cite